Urethral Prolapse 

  • Author: Raymond Rackley, MD; Chief Editor: Edward David Kim, MD, FACS   more...
 
Updated: Jan 23, 2012
 

Background

Urethral prolapse is a circular protrusion of the distal urethra through the external meatus. It is a rarely diagnosed condition that occurs most commonly in prepubertal black females and postmenopausal white women. Even less common is strangulated urethral prolapse.

Vaginal bleeding is the most common presenting symptom of urethral prolapse. Upon examination, round doughnut-shaped mucosa is observed protruding from the urethral opening.

Because urethral prolapse is so rare, the rate of misdiagnosis is high. The differential diagnoses of a urethral mass are broad, ranging from a simple urethral caruncle to rhabdomyosarcoma. Increased physician awareness and early recognition of urethral prolapse avoids unnecessary examinations and patient anxiety.

Management of urethral prolapse ranges from medical therapy that consists of topical estrogen use to conservative surgical excision when medical therapies fail.

Next

History of the Procedure

Solingen first described urethral prolapse in 1732. It is a benign extrusion of the terminal urethra that is associated with vaginal bleeding. Most authors believe urethral prolapse is restricted to the terminal urethra.

Various treatments have been used for this type of lesion. In the past, treatment was primarily surgical. Currently, conservative therapy with topical agents is the preferred initial therapy for uncomplicated urethral prolapse.

Failure of medical therapy for strangulated urethral prolapse warrants surgical intervention. Many different surgical procedures, ranging from simple manual reduction to complete surgical excision, have been described. Surgical excision has a high cure rate and is the most definitive therapy.

Procedures such as cautery, cryotherapy, and ligation of the prolapsed urethra over a Foley catheter are no longer routinely practiced.

Previous
Next

Problem

Urethral prolapse is defined as the complete eversion of the terminal urethra from the external meatus (see image below). Although infrequently reported in the literature, it is a common disorder among postmenopausal women and prepubertal girls. Urethral prolapse must be distinguished from urethral caruncle, in which one quarter of the urethral mucosa protrudes.

Pediatric urethral prolapse. Note the complete cirPediatric urethral prolapse. Note the complete circular eversion of the distal urethral mucosa.
Previous
Next

Epidemiology

Frequency

Urethral prolapse is relatively uncommon and has a bimodal age distribution.

It occurs almost exclusively in black girls younger than 10 years, with an average age at presentation of 4 years. Although most children with urethral prolapse are black, one report found that 61% of affected children are white.

In adults, urethral prolapse most commonly occurs in white women after menopause. Approximately 86% of the postmenopausal women with urethral prolapse are white.

English literature reports 270 cases involving children and 46 cases involving adults.

One report of urethral prolapse in identical twins suggests that heredity may play a role.[1]

Strangulated urethral prolapse is more common in adults than in children.

Previous
Next

Etiology

The exact cause of urethral prolapse remains unknown; however, several theories have been proposed. These theories may be divided into congenital or acquired defects.

  • Congenital defects include weak pelvic floor structures such as inadequate pelvic attachments and urethral hypermobility. Proposed theories include intrinsic abnormalities of the urethra (eg, an abnormally patulous urethra, a wide urethra, redundant mucosa). Other hypotheses include neuromuscular disorders, urethral malposition, submucosal weakness, or deficient elastic tissue.
  • Acquired defects include trauma during birth, such as prolonged vaginal delivery or perineal tears. Less likely causes include trauma caused by rape, masturbation, debility, and malnutrition. Periurethral bulking agent injection is an unusual cause of urethral prolapse. A popular theory involves a weakened attachment between the inner longitudinal and outer circular-oblique smooth muscle layers of the urethra. Separation of the 2 muscle layers, coincident with episodic increases in intra-abdominal pressure, may predispose to urethral prolapse.

Risk factors for urethral prolapse in children include increased intra-abdominal pressure as a result of chronic coughing or constipation. The relationship between genital trauma and urethral prolapse remains controversial. In elderly people, poor nutrition and hygiene have been reported as additional possible risk factors. Loss of estrogen at menopause has also been cited as a risk factor. Urethral prolapse in elderly women has become much less common since the introduction of estrogen replacement therapy.

Previous
Next

Pathophysiology

Urethral prolapse primarily involves the distal female urethra. The urethra is composed of inner longitudinal and outer circular-oblique smooth muscle layers. Usually, a natural cleavage plane is present between the inner and outer muscle layers. In a healthy female urethra, this cleavage plane firmly adheres to the opposing muscle layers.

A prolapsed urethra may result from these 2 muscle layers separating after a sudden episodic increase in intra-abdominal pressure. Disruption of these muscle layers results in complete and circular eversion of the urethral mucosa through the external meatus and leads to urethral prolapse. Swelling and congestion of the prolapsed mucosa create a purse-string effect around the distal urethra, impeding venous return and exacerbating vascular congestion. If left untreated, urethral prolapse may progress to strangulation and eventual necrosis of the protruding tissues.

The fundamental anatomical defect of urethral prolapse is the separation of the longitudinal and circular-oblique smooth muscle layers. Surgical apposition of these smooth muscle layers is curative.

Previous
Next

Presentation

The two types of urethral prolapse include prepubertal and postmenopausal. Clinical presentation is different for both groups.

Prepubertal urethral prolapse is predominantly asymptomatic. Often, urethral prolapse is an incidental finding during routine examination. The most common presentation is vaginal bleeding associated with a periurethral mass. Symptomatic children present with bloody spotting on their underwear or diapers. Hematuria is uncommon. Until urethral prolapse is definitively diagnosed, the presence of blood in the genital area should raise the suspicion of sexual abuse.

Voiding disturbances are typically rare in the pediatric population, but when they are present, patients may report dysuria, urinary frequency, or introital pain. Again, hematuria is uncommon. Children may report genital pain if the prolapsed mucosa becomes very large or if thrombosis and gangrene have developed. Furthermore, although reportedly a nonobstructive lesion, acute urinary retention secondary to urethral prolapse has been reported in a young girl.[2]

In contrast, patients with postmenopausal urethral prolapse are often symptomatic. Vaginal bleeding associated with voiding symptoms is fairly common. Affected women may report dysuria, urinary frequency or urgency, and nocturia. Either microscopic or gross hematuria may be present. If the prolapsed urethra is large, the mucosal mass may become strangulated, which results in venous obstruction, thrombosis, and necrosis of the prolapsed tissue. Patients with strangulated urethral prolapse present with suprapubic pain, dysuria, hematuria, and urethral bleeding. Attendant urinary tract infection is also common.

Upon physical examination, urethral prolapse appears as a doughnut-shaped mass protruding from the anterior vaginal wall. In children, a pinkish orange congested mass may be observed at the center of the urethral meatus. The mass may be painful and tender to palpation. The mucosa is ulcerated in most cases and usually bleeds upon contact. In adults, urethral prolapse appears as erythematous inflamed mucosa protruding from the urethral meatus. The congested mucosa may appear bright red or dark and cyanotic. Depending on the evolution of the process, the prolapsed tissue may appear infected, ulcerated, or necrotic.

Urethral prolapse is diagnosed by verifying that a central opening is present within the prolapsed tissue and that this opening is the urethral meatus. In children, observation during voiding or catheterization of the central opening is diagnostic. In adults, urethral catheterization or cystourethroscopy helps verify the presence of the urethral meatus. The absence of a urethral meatus at the center of the prolapsed mucosa precludes the diagnosis of urethral prolapse.

The initial diagnosis of urethral prolapse made by the referring pediatrician or emergency department physician is often erroneous because of the rarity of this condition. When evaluating a urethral mass, the differential diagnoses should include urethral or vaginal malignancy, urethral caruncle, ectopic ureterocele, condyloma, and rhabdomyosarcoma. Routine evaluation with intravenous pyelograms and voiding cystourethrograms is unnecessary except in patients who may have evidence of malignancy, prolapsed ectopic ureterocele, or abnormalities in the ureterovesical junction.

Urethral masses that were actually sarcoma botryoides or endodermal sinus tumors have been misdiagnosed as urethral prolapse. Urethral leiomyomas and malakoplakia have also been misdiagnosed as urethral prolapse.

If the diagnosis is not completely certain after a detailed history and careful physical examination, the patient should be examined under general anesthesia to rule out more serious lesions. Surgical excision and pathologic examination confirm the diagnosis.

Although urethral prolapse does not have pathognomonic features, histological examination reveals ulcerated polypoid tissue composed of fibrovascular stroma with dilated veins and a few organized thrombi. Mucosal edema, vascular thrombosis, and inflammatory cells may also be present.

Strangulated urethral prolapse appears to be more common in the adult population than in the pediatric population. Patients with strangulated urethral prolapse may report suprapubic tenderness and severe pain during urination. Urethral prolapse is often associated with urinary tract infection. The diagnosis of strangulated urethral prolapse is predicated upon the discovery of an extremely painful, cyanotic, circular mass surrounding the external meatus, and this condition requires emergency surgical excision.

For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center. Also, see eMedicine's patient education article Prolapsed Bladder.

Previous
Next

Indications

Surgical excision is justified in young patients with symptoms of urethral prolapse or with recurrent urethral prolapse.

Optimal treatment for postmenopausal women presenting with symptoms of urethral prolapse or strangulated urethral prolapse ranges from long-term topical vaginal estrogen therapy to simple excision followed by a short period of urethral catheterization. Long-term treatment following simple surgical excision would then consist of topical vaginal estrogen cream.

Previous
Next

Relevant Anatomy

The adult female urethra is 4 cm long and extends from the bladder neck to the external meatus. The mucosa of the female urethra is lined by transitional cell epithelium that gradually changes to nonkeratinizing squamous epithelium from the bladder neck to the external urethral meatus. Small periurethral secretory glands line the wall of the urethra to provide lubrication to the urethral mucosa. These periurethral glands converge at the distal urethra as Skene glands and empty through 2 small ducts on either side of the external meatus.

The submucosa of the female urethra is composed of a rich vascular network of spongy tissue. It nourishes the urethral epithelium and the underlying mucous glands. Both the mucosa and the submucosa are responsible for providing a part of the female continence mechanism, the mucosal seal.

The mucosal epithelium and the submucosal vascular plexus are highly responsive to estrogen. Loss of estrogen at menopause may result in atrophy and loss of the mucosal seal, causing intrinsic sphincter dysfunction. Intrinsic sphincter deficiency is a complex form of stress urinary incontinence.

The female urethra contains 2 layers of smooth muscle—the inner longitudinal layer and the outer circular-oblique layer. The inner longitudinal smooth muscle layer is thicker and continues from the bladder neck to the external meatus. The outer circular-oblique smooth muscle layer encases the longitudinal fibers throughout the length of the urethra. Usually, these 2 layers adhere to each other by means of strong connective tissue. Weakening or separation of these 2 layers leads to complete urethral prolapse.

The female bladder neck functions as an internal sphincter, but it possesses little adrenergic innervation and has limited sphincteric action. The striated urethral sphincter is composed of slow- (type I) and fast-twitch (type II) muscle fibers that form a complete ring around the proximal urethra. The striated urethral sphincter receives dual somatic innervation from the pudendal and pelvic somatic nerves to provide a normal resting urethral closure pressure.

Little sympathetic innervation is found in the female urethra, but parasympathetic cholinergic fibers are found throughout the smooth muscle fibers. Activation of the parasympathetic fibers causes the inner longitudinal smooth muscle of the urethra to contract synchronously with the detrusor. Contraction of the longitudinal fibers shortens and widens the urethra to allow normal urination.

Previous
Next

Contraindications

Those in whom topical estrogen vaginal cream use is contraindicated may include women who have survived breast cancer. Consulting with the patient's oncologist and urologist is necessary. Those in whom surgery is contraindicated include women and children with minimal symptoms who are experiencing urethral prolapse for the first time and those who cannot tolerate a local, regional, or general anesthesia.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Raymond Rackley, MD  Professor of Surgery, Cleveland Clinic Lerner College of Medicine; Staff Physician, Center for Pelvic Medicine and Pelvic Reconstruction, Glickman Urological Institute, Joint Appointment with Women's Institute Cleveland Clinic Foundation

Raymond Rackley, MD is a member of the following medical societies: American Urological Association

Disclosure: Pfizer, Novartis, Proctor & Gamble, Allergan Honoraria None; Pfizer, Novartis, Proctor & Gamble, Allergan Consulting fee Other

Coauthor(s)

Sandip P Vasavada, MD  Physician, Associate Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Center for Female Urology and Genitourinary Reconstructive Surgery, The Glickman Urological and Kidney Institute; Joint Appointment with Women's Institute, Cleveland Clinic

Sandip P Vasavada, MD is a member of the following medical societies: American Urogynecologic Society, American Urological Association, International Continence Society, Society for Urology and Engineering, and Society of Urodynamics and Female Urology

Disclosure: Pfizer Consulting fee Speaking and teaching; NDI Medical, LLC Ownership interest Review panel membership; AMS Consulting fee Consulting

Farzeen Firoozi, MD  Clinical Fellow, Center for Female Urology and Pelvic Reconstructive Surgery, Glickman Urological Institute, Cleveland Clinic Foundation

Farzeen Firoozi, MD is a member of the following medical societies: American Medical Association and American Urological Association

Disclosure: Nothing to disclose.

Michael S Ingber, MD  Clinical Fellow, Glickman Urological and Kidney Institute of the Cleveland Clinic

Disclosure: Nothing to disclose.

Specialty Editor Board

Allen Donald Seftel  MD, Professor of Urology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School; Head, Division of Urology, Director, Urology Residency Training Program, Cooper University Hospital

Allen Donald Seftel is a member of the following medical societies: American Urological Association

Disclosure: lilly Consulting fee Consulting; sanofi-aventis Consulting fee Consulting; auxilium Consulting fee Consulting; solvay Consulting fee Consulting; plethora Grant/research funds clinical trial; endo Consulting fee Consulting; nature publishing journal editor

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Mark Jeffrey Noble, MD  Consulting Staff, Urologic Institute, Cleveland Clinic Foundation

Mark Jeffrey Noble, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Kansas Medical Society, Sigma Xi, Society of University Urologists, and Southwest Oncology Group

Disclosure: Nothing to disclose.

J Stuart Wolf Jr, MD, FACS  The David A Bloom Professor of Urology, Director, Division of Endourology and Stone Disease, Department of Urology, University of Michigan Medical School

J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Chief Editor

Edward David Kim, MD, FACS  Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, Sexual Medicine Society of North America, and Tennessee Medical Association

Disclosure: Lilly Consulting fee Advisor; Astellas Consulting fee Speaking and teaching; Watson Consulting fee Speaking and teaching; Allergan Consulting fee Speaking and teaching

References
  1. Mitre A, Nahas W, Gilbert A, et al. Urethral prolapse in girls: familial case. J Urol. Jan 1987;137(1):115. [Medline].

  2. Lai HH, Hurtado EA, Appell RA. Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection. Int Urogynecol J Pelvic Floor Dysfunct. Sep 2008;19(9):1315-7. [Medline].

  3. Redman JF. Conservative management of urethral prolapse in female children. Urology. May 1982;19(5):505-6. [Medline].

  4. Wright M. Urethral prolapse in children--alternative management. S Afr Med J. Oct 17 1987;72(8):551-2. [Medline].

  5. Jerkins GR, Verheeck K, Noe HN. Treatment of girls with urethral prolapse. J Urol. Oct 1984;132(4):732-3. [Medline].

  6. Holbrook C, Misra D. Surgical management of urethral prolapse in girls: 13 years' experience. BJU Int. Nov 11 2011;[Medline].

  7. Haverkorn RM, Williams BJ, Kubricht WS 3rd, Gomelsky A. Is obesity a risk factor for failure and complications after surgery for incontinence and prolapse in women?. J Urol. Mar 2011;185(3):987-92. [Medline].

  8. Lowe FC, Hill GS, Jeffs RD, Brendler CB. Urethral prolapse in children: insights into etiology and management. J Urol. Jan 1986;135(1):100-3. [Medline].

  9. Anveden-Hertzberg L, Gauderer MW, Elder JS. Urethral prolapse: an often misdiagnosed cause of urogenital bleeding in girls. Pediatr Emerg Care. Aug 1995;11(4):212-4. [Medline].

  10. Desai SR, Cohen RC. Urethral prolapse in a premenarchal girl: case report and literature review. Aust N Z J Surg. Sep 1997;67(9):660-2. [Medline].

  11. Devine PC, Kessel HC. Surgical correction of urethral prolapse. J Urol. Jun 1980;123(6):856-7. [Medline].

  12. Falandry L. [Urethral prolapse in young black girls. Report of 12 cases]. Prog Urol. Jun 1996;6(3):392-7. [Medline].

  13. Fletcher SG, Lemack GE. Benign masses of the female periurethral tissues and anterior vaginal wall. Curr Urol Rep. Sep 2008;9(5):389-96. [Medline].

  14. Goh JT, Krause HG, ALIA. Postpartum urethral prolapse. Aust N Z J Obstet Gynaecol. Nov 1998;38(4):477-8. [Medline].

  15. Harris RL, Cundiff GW, Coates KW, et al. Urethral prolapse after collagen injection. Am J Obstet Gynecol. Mar 1998;178(3):614-5. [Medline].

  16. Kisanga RE, Aboud MM. Urethral mucosa prolapse in young girls. Cent Afr J Med. Jan 1996;42(1):31-3. [Medline].

  17. Kleinjan JH, Vos P. Strangulated urethral prolapse. Urology. Apr 1996;47(4):599-601. [Medline].

  18. Mianne D, Beatrix O, Faure JM, et al. [Strangulated urethral prolapse in a young woman: a rare urological emergency]. Prog Urol. Dec 1994;4(6):1022-6. [Medline].

  19. Nishi M, Toyoda N. [Reposition of the urethra in urethral prolapse]. Shujutsu. Feb 1972;26(2):126-30. [Medline].

  20. Rudin JE, Geldt VG, Alecseev EB. Prolapse of urethral mucosa in white female children: experience with 58 cases. J Pediatr Surg. Mar 1997;32(3):423-5. [Medline].

  21. Sen I, Onaran M, Tokgoz H, Tan MO, Biri H, Bozkirli I. Prolapse of a simple ureterocele presenting as a vulval mass in a woman. Int J Urol. Apr 2006;13(4):447-8. [Medline].

  22. Thosaka A, Yamazaki A, Hirokawa M, et al. [Two cases of urethral leiomyoma]. Hinyokika Kiyo. Nov 1988;34(11):2041-6. [Medline].

  23. Turner RW. Urethral prolapse in female children. Urology. Nov 1973;2(5):530-3. [Medline].

Previous
Next
 
Pediatric urethral prolapse. Note the complete circular eversion of the distal urethral mucosa.
Urethral prolapse. Intraoperatively, the prolapsed mucosa is excised in quadrants, and the 2 layers of smooth muscle are apposed together.
Urethral prolapse. Postoperative depiction of a normal-appearing urethra after surgical excision.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.